SATB2 and colorectal carcinoma: Immunohistochemical analysis of 1882 CRC tissues from nine independent cohorts showed that 85% of tumors were positive for SATB2 and 97% for SATB2 and/or cytokeratin 20, suggesting that SATB2 is a highly sensitive marker to distinguish CRC from other cancers [45].